References
- S.OkamotoU.OkamotoAmino-methyl-cyclohexane-carbolic acid: AMCHA. A new potent inhibitor of fibrinolysisKeio J Med111962105115
- D.A.HenryP.A.CarlessA.J.MoxeyAnti-fibrinolytic use for minimising perioperative allogeneic blood transfusionCochrane Database Syst Rev42007CD001886
- The CRASH-2 CollaboratorsEffects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trialLancet37620102332
- The CRASH-2 CollaboratorsThe importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomized controlled trialLancet377201110961101
- <http://www.who.int/selection_medicines/committees/expert/18/en/index.html>.
- C.GuerrieroJ.CairnsP.PerelH.ShakurI.RobertsCost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trialPLoS ONE652011e1898710.1371/journal.pone.001898